Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Jamie Miller and Peter Johnson.
Jamie Miller
Connection Strength
22.590
Peter Johnson
  1. Inhaled Tobramycin Usage in Critically Ill Pediatric Patients Without Cystic Fibrosis: A Pediatric Pharmacy-Association, Practice-Based Research Network Survey Study. J Pediatr Pharmacol Ther. 2025 Jun; 30(3):332-339.
    View in: PubMed
    Score: 0.973
  2. Peer Review as a Professional Obligation: Steps and Tips to Becoming a High-Quality Reviewer. J Pediatr Pharmacol Ther. 2024 Dec; 29(6):570-577.
    View in: PubMed
    Score: 0.940
  3. Detectable Concentrations With Inhaled Tobramycin in Critically Ill Infants and Children Following Implementation of Standardized Protocol. Ann Pharmacother. 2024 Sep 28; 10600280241282433.
    View in: PubMed
    Score: 0.927
  4. Training the next generation of peer reviewers: Steps for guiding pharmacy learners through the peer review process. Am J Health Syst Pharm. 2023 Nov 08.
    View in: PubMed
    Score: 0.872
  5. Ketamine infusions as an adjunct for sedation in critically ill children. J Opioid Manag. 2022 Jan-Feb; 18(1):57-68.
    View in: PubMed
    Score: 0.767
  6. Exploring Residency Program Directors, Preceptors, and Residents' Intentions to Participate in Multicenter Pediatric Pharmacy Resident Research Projects. J Pediatr Pharmacol Ther. 2021; 26(7):708-717.
    View in: PubMed
    Score: 0.753
  7. Publication Rates of Pediatric-Focused Resident Research Projects Presented at The Pediatric Pharmacy Association Bruce Parks Memorial Residency Showcase. J Pediatr Pharmacol Ther. 2021; 26(2):163-171.
    View in: PubMed
    Score: 0.722
  8. Small patients, big problems? Pediatric primer for the nonpediatric pharmacist. Am J Health Syst Pharm. 2019 09 16; 76(19):1451-1452.
    View in: PubMed
    Score: 0.654
  9. Prescribing Patterns of Continuous Infusions in Nonobese versus Obese Children Admitted to the Pediatric Intensive Care Unit. J Pediatr Intensive Care. 2019 Dec; 8(4):226-232.
    View in: PubMed
    Score: 0.643
  10. Low-dose versus high-dose methadone for the management of neonatal abstinence syndrome. J Opioid Manag. 2019 Mar/Apr; 15(2):159-167.
    View in: PubMed
    Score: 0.630
  11. Sedation and Analgesia Using Medications Delivered via the Extravascular Route in Children Undergoing Laceration Repair. J Pediatr Pharmacol Ther. 2018 Mar-Apr; 23(2):72-83.
    View in: PubMed
    Score: 0.588
  12. Detectable Concentrations of Inhaled Tobramycin in Critically Ill Children Without Cystic Fibrosis: Should Routine Monitoring Be Recommended? Pediatr Crit Care Med. 2017 Dec; 18(12):e615-e620.
    View in: PubMed
    Score: 0.578
  13. Relationship between rate of fentanyl infusion and time to achieve sedation in nonobese and obese critically ill children. Am J Health Syst Pharm. 2017 Aug 01; 74(15):1174-1183.
    View in: PubMed
    Score: 0.559
  14. Use of continuous-infusion loop diuretics in critically ill children. Pharmacotherapy. 2014 Aug; 34(8):858-67.
    View in: PubMed
    Score: 0.454
  15. Ethacrynic Acid continuous infusions in critically ill pediatric patients. J Pediatr Pharmacol Ther. 2014 Jan; 19(1):49-55.
    View in: PubMed
    Score: 0.440
  16. Selection of the initial methadone regimen for the management of iatrogenic opioid abstinence syndrome in critically ill children. Pharmacotherapy. 2012 Feb; 32(2):148-57.
    View in: PubMed
    Score: 0.385
  17. A pilot study assessing the frequency and complexity of methadone tapers for opioid abstinence syndrome in children discharged to home. Res Social Adm Pharm. 2012 Sep-Oct; 8(5):455-63.
    View in: PubMed
    Score: 0.384
  18. Neurologic withdrawal symptoms following abrupt discontinuation of a prolonged dexmedetomidine infusion in a child. J Pediatr Pharmacol Ther. 2010 Jan; 15(1):38-42.
    View in: PubMed
    Score: 0.334
  19. Pantoprazole-induced thrombocytopenia. Indian J Pediatr. 2009 Dec; 76(12):1278-9.
    View in: PubMed
    Score: 0.332
  20. Response: Commentary: Vasopressin induced hyponatremia in infants <3 months of age in the neonatal intensive care unit. Front Pediatr. 2025; 13:1571691.
    View in: PubMed
    Score: 0.241
  21. Evaluating the Efficacy and Safety of Erythromycin for the Treatment of Gastroparesis in Infants and Children. J Pediatr Pharmacol Ther. 2025 Feb; 30(1):70-77.
    View in: PubMed
    Score: 0.238
  22. Gabapentin for Delirium in Infants in the Neonatal Intensive Care Unit. J Pediatr Pharmacol Ther. 2024 Oct; 29(5):487-493.
    View in: PubMed
    Score: 0.233
  23. Vasopressin induced hyponatremia in infants <3 months of age in the neonatal intensive care unit. Front Pediatr. 2024; 12:1465785.
    View in: PubMed
    Score: 0.232
  24. Incidence of gastrointestinal bleeding with hydrocortisone use in neonates and infants less than three months of age in the neonatal intensive care unit. J Perinatol. 2024 Aug 03.
    View in: PubMed
    Score: 0.229
  25. A Case Series and Review of Literature Describing the Use of Midodrine for Vasopressor Effects in Infants With Congenital Heart Disease. Hosp Pharm. 2024 Oct; 59(5):544-551.
    View in: PubMed
    Score: 0.224
  26. Pharmacologic Management of Sialorrhea in Neonatal and Pediatric Patients. J Pediatr Pharmacol Ther. 2024; 29(1):6-21.
    View in: PubMed
    Score: 0.222
  27. Melatonin Use in Infants Admitted to Intensive Care Units. J Pediatr Pharmacol Ther. 2023; 28(7):635-642.
    View in: PubMed
    Score: 0.219
  28. Variability in opioid conversion calculators in critically ill children transitioned from fentanyl to hydromorphone. Am J Health Syst Pharm. 2023 Oct 25.
    View in: PubMed
    Score: 0.217
  29. Effect of Phytonadione on Correction of Coagulopathy in Pediatric Patients With Septic Shock. J Pediatr Pharmacol Ther. 2023; 28(5):423-429.
    View in: PubMed
    Score: 0.216
  30. Sculpting a teaching and learning curriculum to better meet the career needs of postgraduate year 1 and 2 pharmacy residents. Am J Health Syst Pharm. 2023 Mar 27.
    View in: PubMed
    Score: 0.209
  31. Azithromycin for Eradication of Ureaplasma and Prevention of Bronchopulmonary Dysplasia in Preterm Neonates in the Neonatal Intensive Care Unit. J Pediatr Pharmacol Ther. 2023; 28(1):10-19.
    View in: PubMed
    Score: 0.207
  32. Characterization of early versus late opioid iatrogenic withdrawal syndrome in critically ill children transitioning from fentanyl -infusions to methadone. J Opioid Manag. 2023 Jan-Feb; 19(1):43-56.
    View in: PubMed
    Score: 0.205
  33. Publication rates of pharmacy residents involved in a team-based research program. Am J Health Syst Pharm. 2022 11 22; 79(23):2141-2149.
    View in: PubMed
    Score: 0.204
  34. Impact of Ceftazidime Use on Susceptibility Patterns in a Neonatal Intensive Care Unit: A 7.5-year Evaluation. J Pediatric Infect Dis Soc. 2022 07 21; 11(7):349-350.
    View in: PubMed
    Score: 0.199
  35. Caffeine dosing in premature neonates: impact of birth weight on a pharmacokinetic simulation study. Pediatr Res. 2022 Jun 18.
    View in: PubMed
    Score: 0.198
  36. Vasopressin-Induced Hyponatremia in Infants Following Cardiovascular Surgery. Ann Pharmacother. 2022 Jun 17; 10600280221103576.
    View in: PubMed
    Score: 0.198
  37. Evaluation of Ceftazidime Use in the Neonatal Intensive Care Unit and Association With Cephalosporin-Resistant Gram-Negative Bacteria. Ann Pharmacother. 2022 Dec; 56(12):1325-1332.
    View in: PubMed
    Score: 0.196
  38. Evaluation of the Use of Caffeine Citrate Maintenance Doses >5 mg/kg/day in Preterm Neonates for Apnea of Prematurity. J Pediatr Pharmacol Ther. 2021; 26(6):608-614.
    View in: PubMed
    Score: 0.187
  39. A Pilot Evaluation of the Possible Association of Metronidazole With Neurodevelopmental Outcomes in Premature Neonates. J Pediatr Pharmacol Ther. 2021; 26(5):455-459.
    View in: PubMed
    Score: 0.185
  40. "Reply: Conversion From Continuous Infusion Fentanyl to Hydromorphone in the Pediatric Intensive Care Unit". Ann Pharmacother. 2022 03; 56(3):370-371.
    View in: PubMed
    Score: 0.185
  41. Teaching residents how to deliver active learning during didactic lectures. Am J Health Syst Pharm. 2021 05 24; 78(11):944-948.
    View in: PubMed
    Score: 0.184
  42. Comparison of Amikacin Pharmacokinetics in Neonates With and Without Congenital Heart Disease. J Pediatr Pharmacol Ther. 2021; 26(4):372-378.
    View in: PubMed
    Score: 0.184
  43. Analysis of fentanyl pharmacokinetics, and its sedative effects and tolerance in critically ill children. Pharmacotherapy. 2021 04; 41(4):359-369.
    View in: PubMed
    Score: 0.182
  44. Conversion From Continuous Infusion Fentanyl to Continuous Infusion Hydromorphone in the Pediatric Intensive Care Unit. Ann Pharmacother. 2021 12; 55(12):1439-1446.
    View in: PubMed
    Score: 0.182
  45. Frequency and Severity of Chlorothiazide-Induced Hyponatremia in the Neonatal Intensive Care Unit. Am J Perinatol. 2022 09; 39(12):1354-1361.
    View in: PubMed
    Score: 0.179
  46. Extended Duration Ketamine Infusions in Critically Ill Children: A Case Report and Review of the Literature. J Pediatr Intensive Care. 2021 Sep; 10(3):221-227.
    View in: PubMed
    Score: 0.172
  47. Descriptive study of discharge medications in pediatric patients. SAGE Open Med. 2020; 8:2050312120927945.
    View in: PubMed
    Score: 0.172
  48. Antipsychotic Use in the Prevention and Treatment of Intensive Care Unit Delirium in Pediatric Patients. J Pediatr Pharmacol Ther. 2020; 25(2):81-95.
    View in: PubMed
    Score: 0.167
  49. Which PGY1 Pharmacy Residency Is Right for Me? Advantages and Disadvantages of Pediatric-Focused and Traditional PGY1 Pharmacy Programs. J Pediatr Pharmacol Ther. 2020; 25(4):273-277.
    View in: PubMed
    Score: 0.167
  50. Comparison of Clinical Outcomes and Medication Use of Obese Versus Nonobese Children Admitted to the Pediatric Intensive Care Unit. Hosp Pharm. 2021 Aug; 56(4):287-295.
    View in: PubMed
    Score: 0.166
  51. Prediction and Comparison of Fentanyl Infusion Pharmacokinetics in Obese and Nonobese Children. Pediatr Crit Care Med. 2019 12; 20(12):e556-e564.
    View in: PubMed
    Score: 0.166
  52. A survey of pediatric degree option program graduates in a doctor of pharmacy curriculum: Confidence and initial employment position. Curr Pharm Teach Learn. 2019 Dec; 11(12):1296-1302.
    View in: PubMed
    Score: 0.165
  53. Hyponatremia With Intravenous Sulfamethoxazole/Trimethoprim in Children. Ann Pharmacother. 2020 04; 54(4):351-358.
    View in: PubMed
    Score: 0.165
  54. Impact of Ceftazidime Use on Susceptibility Patterns in the Neonatal Intensive Care Unit. Pediatr Infect Dis J. 2019 06; 38(6):605-607.
    View in: PubMed
    Score: 0.160
  55. Pilot Study Comparing Modified Finnegan Scoring Versus Adjusted Scoring System for Infants With Iatrogenic Opioid Abstinence Syndrome After Cardiothoracic Surgery. J Pediatr Pharmacol Ther. 2019 Mar-Apr; 24(2):148-155.
    View in: PubMed
    Score: 0.157
  56. Assessment of Outcomes With a Sedation Protocol During Laser Photocoagulation in Preterm Infants With Retinopathy of Prematurity. J Pediatr Pharmacol Ther. 2018 Sep-Oct; 23(5):410-416.
    View in: PubMed
    Score: 0.152
  57. Dosing for Fentanyl Infusion in Obese Children: Just Because It's What We Have Always Done Doesn't Mean It Is Right. J Pediatr Pharmacol Ther. 2018 May-Jun; 23(3):223-226.
    View in: PubMed
    Score: 0.149
  58. Description of a pediatric degree option program in a doctorate of pharmacy curriculum and its impact on pediatric-focused advanced pharmacy practice experience rotations and faculty scholarly productivity. Curr Pharm Teach Learn. 2018 05; 10(5):627-636.
    View in: PubMed
    Score: 0.147
  59. Sedation Protocol During Bevacizumab Intravitreal Injection in Preterm Infants With Retinopathy of Prematurity. J Pediatr Pharmacol Ther. 2018 Jan-Feb; 23(1):34-40.
    View in: PubMed
    Score: 0.145
  60. Prevalence of Unrounded Medication Doses and Associated Factors Among Hospitalized Pediatric Patients. J Pediatr Pharmacol Ther. 2017 Jul-Aug; 22(4):286-292.
    View in: PubMed
    Score: 0.140
  61. Comparison of Amikacin Pharmacokinetics in Neonates Following Implementation of a New Dosage Protocol. J Pediatr Pharmacol Ther. 2017 Jan-Feb; 22(1):33-40.
    View in: PubMed
    Score: 0.136
  62. Clonidine for Sedation and Analgesia and Withdrawal in Critically Ill Infants and Children. Pharmacotherapy. 2016 12; 36(12):1290-1299.
    View in: PubMed
    Score: 0.135
  63. Characterization of Tolerance in Children during Fentanyl Continuous Infusions. J Pediatr Intensive Care. 2017 Jun; 6(2):83-90.
    View in: PubMed
    Score: 0.131
  64. Assessment of inpatient admissions and top 25 medications for obese pediatric patients at two academic hospitals. Am J Health Syst Pharm. 2016 Aug 15; 73(16):1243-9.
    View in: PubMed
    Score: 0.131
  65. Dosing of Vasopressin in Critically Ill Children: Implications for Medication Safety. Pediatr Crit Care Med. 2016 Mar; 17(3):277-8.
    View in: PubMed
    Score: 0.128
  66. Ketamine Continuous Infusions in Critically Ill Infants and Children. Ann Pharmacother. 2016 Mar; 50(3):234-41.
    View in: PubMed
    Score: 0.127
  67. Caregiver Perception, Self-efficacy, and Knowledge of Methadone Tapers for Children With Iatrogenic Opioid Abstinence Syndrome. J Pharm Technol. 2016 Jun; 32(3):104-115.
    View in: PubMed
    Score: 0.126
  68. Non-Intravenous Sedatives and Analgesics for Procedural Sedation for Imaging Procedures in Pediatric Patients. J Pediatr Pharmacol Ther. 2015 Nov-Dec; 20(6):418-30.
    View in: PubMed
    Score: 0.125
  69. "Once-daily" versus "extended-interval" administration of aminoglycosides in neonates: need for standard terminology. Am J Health Syst Pharm. 2014 Dec 15; 71(24):2108-9.
    View in: PubMed
    Score: 0.118
  70. Pseudohyperphosphatemia in children treated with liposomal amphotericin B. Am J Health Syst Pharm. 2014 Sep 01; 71(17):1462-8.
    View in: PubMed
    Score: 0.115
  71. Propylene glycol-induced lactic acidosis in a child receiving a pentobarbital continuous infusion. J Pediatr Intensive Care. 2014 Jun; 3(2):73-77.
    View in: PubMed
    Score: 0.113
  72. Association of fentanyl with neurodevelopmental outcomes in very-low-birth-weight infants. Ann Pharmacother. 2014 Mar; 48(3):335-42.
    View in: PubMed
    Score: 0.110
  73. External validation of the medication taper complexity score for methadone tapers in children with opioid abstinence syndrome. Ann Pharmacother. 2014 Feb; 48(2):187-95.
    View in: PubMed
    Score: 0.109
  74. Acetazolamide in critically ill neonates and children with metabolic alkalosis. Ann Pharmacother. 2013 Sep; 47(9):1130-5.
    View in: PubMed
    Score: 0.108
  75. Implementation of a bowel regimen protocol in critically ill children: A pilot study. J Pediatr Intensive Care. 2013 Jun; 2(2):63-69.
    View in: PubMed
    Score: 0.106
  76. Sedation and analgesia in critically ill children. AACN Adv Crit Care. 2012 Oct-Dec; 23(4):415-34; quiz 435-6.
    View in: PubMed
    Score: 0.101
  77. Bumetanide continuous-infusion dosing in critically ill pediatric patients. Am J Health Syst Pharm. 2012 Sep 01; 69(17):1458, 1460-1.
    View in: PubMed
    Score: 0.100
  78. Evaluation of initial methadone dosing for prevention of iatrogenic opioid abstinence syndrome in children. J Pediatr Intensive Care. 2012 Jun; 1(2):105-113.
    View in: PubMed
    Score: 0.099
  79. Vancomycin dosage in overweight and obese children. Am J Health Syst Pharm. 2011 Nov 01; 68(21):2062-8.
    View in: PubMed
    Score: 0.095
  80. Continuous-infusion neuromuscular blocking agents in critically ill neonates and children. Pharmacotherapy. 2011 Jun; 31(6):609-20.
    View in: PubMed
    Score: 0.092
  81. Lofexidine, an {alpha}2-receptor agonist for opioid detoxification. Ann Pharmacother. 2010 Feb; 44(2):343-51.
    View in: PubMed
    Score: 0.083
  82. Evaluation of inpatient admissions and potential antimicrobial and analgesic dosing errors in overweight children. Ann Pharmacother. 2010 Jan; 44(1):35-42.
    View in: PubMed
    Score: 0.083
  83. Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. Ann Pharmacother. 2009 Sep; 43(9):1506-11.
    View in: PubMed
    Score: 0.081
  84. Effectiveness of trimethoprim/sulfamethoxazole for children with chronic active otitis media. Pediatrics. 2007 Dec; 120(6):1403; author reply 1403-4.
    View in: PubMed
    Score: 0.072
  85. Rates of Stress Ulcer Prophylaxis Deprescribing in Children Receiving Usual versus High-Dose Corticosteroids in the Pediatric Intensive Care Unit with Status Asthmaticus. Hosp Pharm. 2024 Dec; 59(6):677-683.
    View in: PubMed
    Score: 0.057
  86. Ketamine Use in Adult and Pediatric Patients Receiving Extracorporeal Membrane Oxygenation (ECMO): A Systematic Review. J Pharm Pract. 2023 Sep 06; 8971900231198928.
    View in: PubMed
    Score: 0.054
  87. Efficacy and Safety of Prolonged Magnesium Sulfate Infusions in Children With Refractory Status Asthmaticus. Front Pediatr. 2022; 10:860921.
    View in: PubMed
    Score: 0.049
  88. Correction to: Key articles and guidelines for the pediatric clinical pharmacist from 2019 and 2020. Am J Health Syst Pharm. 2022 May 24; 79(11):823.
    View in: PubMed
    Score: 0.049
  89. Key articles and guidelines for the pediatric clinical pharmacist from 2019 and 2020. Am J Health Syst Pharm. 2022 02 18; 79(5):364-384.
    View in: PubMed
    Score: 0.048
  90. Minimum Requirements for Core Competency in Pediatric Pharmacy Practice. J Pediatr Pharmacol Ther. 2015 Nov-Dec; 20(6):481-4.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.